The Official Medicare Set Aside Blog And Information Resource

CMS Will Maintain $750 Recovery Threshold for 2021

CMS, Mandatory Insurer Reporting, Medicare Set-Aside Blog, MSP News on November 30, 2020
Posted by Shannon Flynn

The Strengthening Medicare and Repaying Taxpayers Act of 2012 (the SMART Act) requires the Centers for Medicare & Medicaid Services (CMS) to publish an annual threshold for recovery in November, each year.  This threshold amount reflects an amount for which CMS will not spend more on collections than a claim is likely to yield. On November […] Continue

CMS BCRC to Host Webinar on NGHP Beneficiary Recovery Process

CMS, Conditional Payments, Medicare Set-Aside Blog on November 12, 2020
Posted by Shannon Flynn

The Centers for Medicare & Medicaid Services (CMS) recently announced that it will be hosting a Benefits Coordination & Recover Center Non-Group Health Plan Beneficiary Recovery Process webinar on December 9, 2020 at 1:00 pm ET. The webinar will focus on the Medicare Secondary Payer (MSP) recovery process when a Medicare beneficiary receives a settlement, […] Continue

New CMS Release: Commercial Repayment Center (CRC) Non-Group Health Plan (NGHP) Applicable Plan Appeal Guide

CMS, Conditional Payments, CRC, Medicare Set-Aside Blog on November 3, 2020
Posted by Jessica M. Wingenroth, JD

In follow-up to their September 2020 webinar on Non-Group Health Plan (NGHP) appeals, yesterday the Centers for Medicare & Medicaid Services (CMS) converted the slides from that presentation, publishing them as: Commercial Repayment Center Non-Group Health Plan Applicable Plan Appeal Guide, located under the downloads section of the Insurer NGHP Recovery CMS page. There were […] Continue

FDA Requires Stronger Warnings for Benzodiazepines   

FDA, Medicare Set-Aside Blog on October 22, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

On September 23, 2020, the FDA Drug Safety Commission announced that manufacturers of benzodiazepines will be required to update the boxed warning within the prescribing information for these products. Benzodiazepines, a group of medications that includes Ativan (lorazepam), Xanax (alprazolam) and others, are commonly used to treat anxiety disorders, panic disorder, insomnia, certain types of […] Continue